COCBC17/1
TARGET AUDIENCE This activity is intended for medical oncologists, oncology fellows, oncology nurses and other healthcare providers involved in the treatment of breast cancer. OVERVIEW OF ACTIVITY COCLymphoma16/7
TARGET AUDIENCE This activity is intended for medical oncologists, radiation oncologists, nurses and other healthcare providers involved in the treatment of lymphomas and chronic lymphocytic leukemia (CLL). OVERVIEW OF ACTIVITY COCLymphoma16/6
TARGET AUDIENCE This activity is intended for medical oncologists, radiation oncologists, nurses and other healthcare providers involved in the treatment of lymphomas and chronic lymphocytic leukemia (CLL). OVERVIEW OF ACTIVITY COCLymphoma16/5
TARGET AUDIENCE This activity is intended for medical oncologists, radiation oncologists, nurses and other healthcare providers involved in the treatment of lymphomas and chronic lymphocytic leukemia (CLL). OVERVIEW OF ACTIVITY COCLymphoma16/4
TARGET AUDIENCE This activity is intended for medical oncologists, radiation oncologists, nurses and other healthcare providers involved in the treatment of lymphomas and chronic lymphocytic leukemia (CLL). OVERVIEW OF ACTIVITY COCLymphoma16/3
TARGET AUDIENCE This activity is intended for medical oncologists, radiation oncologists, nurses and other healthcare providers involved in the treatment of lymphomas and chronic lymphocytic leukemia (CLL). OVERVIEW OF ACTIVITY Consensus or Controversy: Clinical Investigators Provide Their Perspectives on Practical Issues and Research Questions in the Management of Non-Small Cell Lung Cancer
These audio proceedings from an Independent Satellite Symposium held at the 2012 ASCO Annual meeting offer the perspectives of 5 renowned international clinical investigators on a number of controversial management and research issues. This content is available in a number of formats for listening on the go with a mobile device or at home on a computer. COCLymphoma16/2TARGET AUDIENCE COCLymphoma16/1TARGET AUDIENCE BCU116/VideoTARGET AUDIENCE
Regional Meetings 2017
Beyond the Guidelines: Clinical Investigators Provide Perspectives on Biomarker-Guided Decision-Making for Patients with Non-Small Cell Lung CancerResearch To Practice is pleased to offer practicing oncologists and other allied healthcare professionals throughout the United States the opportunity to attend an educational activity focused on the management of non-small cell lung cancer (NSCLC). Each session in this regional series will include a blend of didactic minipresentations, video case presentations from clinicians in practice, interactive polling of the audience using keypad devices and follow-up discussion and audience Q&A. If you are interested in hosting a session at your institution, please contact our Meeting Services department at Meetings@ResearchToPractice.com or call (800) 233-6153. Schedule of Events:
Each 1-hour session will include 4 topic modules focused on the current management of biologically defined subsets of NSCLC and emerging research information on novel agents and strategies under active investigation. Each module will employ an identical format and include:
Each session will conclude with a 5-minute Q&A segment
STEERING COMMITTEE MEMBERS AND PARTICIPATING FACULTY
Julie R Brahmer, MD
Director, Thoracic Oncology Program Interim Director, Johns Hopkins Kimmel Cancer Center at Bayview Associate Professor of Oncology Sidney Kimmel Comprehensive Cancer Center Johns Hopkins School of Medicine Baltimore, Maryland Paul A Bunn Jr, MD Distinguished Professor and James Dudley Chair in Cancer Research University of Colorado Cancer Center Aurora, Colorado D Ross Camidge, MD, PhD Professor of Medicine/Oncology Joyce Zeff Chair in Lung Cancer Research University of Colorado Cancer Center Aurora, Colorado Alexander E Drilon, MD Clinical Director Developmental Therapeutics Clinic Assistant Attending Physician Thoracic Oncology Service Memorial Sloan Kettering Cancer Center New York, New York David E Gerber, MD Associate Professor Division of Hematology-Oncology Associate Director for Clinical Research Co-Leader, Experimental Therapeutics Program Co-Director, Lung Disease Oriented Team Harold C Simmons Comprehensive Cancer Center University of Texas Southwestern Medical Center Dallas, Texas Sarah B Goldberg, MD, MPH Assistant Professor of Medicine Medical Oncology Yale Cancer Center New Haven, Connecticut Roy S Herbst, MD, PhD Ensign Professor of Medicine (Oncology) Professor of Pharmacology Chief of Medical Oncology Director, Thoracic Oncology Research Program Associate Director for Translational Research Yale Comprehensive Cancer Center Yale School of Medicine Smilow Cancer Hospital New Haven, Connecticut John V Heymach, MD, PhD Professor and Chair Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston, Texas Leora Horn, MD, MSc Associate Professor of Medicine Clinical Director Thoracic Oncology Research Program Assistant Vice Chairman for Faculty Development Vanderbilt University Medical Center Nashville, Tennessee Edward S Kim, MD Professor and Chair Department of Solid Tumor Oncology and Investigational Therapeutics Levine Cancer Institute Carolinas HealthCare System Charlotte, North Carolina Mark G Kris, MD William and Joy Ruane Chair in Thoracic Oncology Attending Physician, Thoracic Oncology Service Memorial Sloan Kettering Cancer Center New York, New York Corey J Langer, MD Director of Thoracic Oncology Abramson Cancer Center Professor of Medicine Perelman School of Medicine University of Pennsylvania Vice Chair, Radiation Therapy Oncology Group Philadelphia, Pennsylvania Renato G Martins, MD, MPH Stephen H Petersdorf Endowed Chair in Cancer Care Associate Medical Director Solid Tumor Adult Oncology Seattle Cancer Care Alliance Professor University of Washington Seattle, Washington
Joel W Neal, MD, PhD
Assistant Professor of Medicine Division of Oncology Stanford Cancer Institute Stanford University Palo Alto, California Paul K Paik, MD Assistant Attending Physician Clinical Director, Thoracic Oncology Service Memorial Sloan Kettering Cancer Center New York, New York Jyoti D Patel, MD Professor of Medicine The University of Chicago Chicago, Illinois Nathan A Pennell, MD, PhD Associate Professor Hematology and Medical Oncology Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Director, Cleveland Clinic Lung Cancer Medical Oncology Program Cleveland, Ohio Suresh S Ramalingam, MD Professor of Hematology and Medical Oncology Assistant Dean for Cancer Research Emory University School of Medicine Deputy Director, Winship Cancer Institute Atlanta, Georgia Lecia V Sequist, MD, MPH Associate Professor of Medicine Harvard Medical School Center for Thoracic Cancers Massachusetts General Hospital Cancer Center Boston, Massachusetts Mark A Socinski, MD Executive Medical Director Member, Thoracic Oncology Program Florida Hospital Cancer Institute Orlando, Florida David R Spigel, MD Program Director, Lung Cancer Research Sarah Cannon Research Institute Nashville, Tennessee Thomas E Stinchcombe, MD Thoracic Oncology Program Duke University Medical Center Durham, North Carolina Anne S Tsao, MD Professor Director, Mesothelioma Program Director, Thoracic Chemo-Radiation Program The University of Texas MD Anderson Cancer Center Department of Thoracic/Head and Neck Medical Oncology Houston, Texas Everett E Vokes, MD John E Ultmann Professor Chairman, Department of Medicine Physician-in-Chief University of Chicago Medicine and Biological Sciences Chicago, Illinois Heather Wakelee, MD Associate Professor of Medicine Division of Oncology Stanford University School of Medicine Stanford Cancer Institute Stanford, California Project Chair Neil Love, MD President Research To Practice Miami, Florida
Target Audience:
CME Credit Form: GICancers16/RoundtableTARGET AUDIENCE LCU116/VideoTARGET AUDIENCE VPMPN116/VideoTARGET AUDIENCE  |